Skip to main content

Respiratory Syncytial Virus Topic Center

Featured Article

News
03/17/2025
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for...
03/17/2025
Pharmacy Learning Network
News
01/21/2025
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo...
01/21/2025
Pharmacy Learning Network
News
01/10/2025
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened...
01/10/2025
Pharmacy Learning Network
News
12/17/2024
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent...
12/17/2024
Pharmacy Learning Network
News
12/06/2024
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus...
12/06/2024
Pharmacy Learning Network
News
11/22/2024
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the...
11/22/2024
Pharmacy Learning Network
News
11/08/2024
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of...
11/08/2024
Pharmacy Learning Network
News
10/18/2024
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature...
10/18/2024
Pharmacy Learning Network
News
10/04/2024
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus...
10/04/2024
Pharmacy Learning Network
News
09/10/2024
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus...
09/10/2024
Pharmacy Learning Network
News
08/26/2024
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics...
08/26/2024
Pharmacy Learning Network

Newsfeed

News
03/17/2025
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for...
03/17/2025
Pharmacy Learning Network
News
01/21/2025
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo...
01/21/2025
Pharmacy Learning Network
News
01/10/2025
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened...
01/10/2025
Pharmacy Learning Network
News
12/17/2024
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent...
12/17/2024
Pharmacy Learning Network
News
12/06/2024
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus...
12/06/2024
Pharmacy Learning Network
News
11/22/2024
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the...
11/22/2024
Pharmacy Learning Network
News
11/08/2024
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of...
11/08/2024
Pharmacy Learning Network
News
10/18/2024
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature...
10/18/2024
Pharmacy Learning Network
News
10/04/2024
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus...
10/04/2024
Pharmacy Learning Network
News
09/10/2024
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus...
09/10/2024
Pharmacy Learning Network
News
03/20/2025
ICU Medical, Inc has recalled potassium chloride injection (20 mEq in 100 mL) due to a labeling error that may misrepresent the product’s strength, posing a risk of dosing confusion.
ICU Medical, Inc has recalled potassium chloride injection (20 mEq in 100 mL) due to a labeling error that may misrepresent the product’s strength, posing a risk of dosing confusion.
ICU Medical, Inc has recalled...
03/20/2025
Pharmacy Learning Network
News
03/20/2025
Breckenridge Pharmaceutical has recalled Duloxetine Delayed-Release Capsules (60 mg) due to the presence of N-nitroso-duloxetine impurity exceeding US Food and Drug Administration limits.
Breckenridge Pharmaceutical has recalled Duloxetine Delayed-Release Capsules (60 mg) due to the presence of N-nitroso-duloxetine impurity exceeding US Food and Drug Administration limits.
Breckenridge Pharmaceutical has...
03/20/2025
Pharmacy Learning Network
News
03/20/2025
A Class III recall has been initiated for Livalo (pitavastatin) tablets due to the presence of foreign tablets or capsules in the product.
A Class III recall has been initiated for Livalo (pitavastatin) tablets due to the presence of foreign tablets or capsules in the product.
A Class III recall has been...
03/20/2025
Pharmacy Learning Network
News
03/17/2025
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for...
03/17/2025
Pharmacy Learning Network
News
03/12/2025
Safecor Health, LLC has issued a voluntary nationwide recall of ferrous sulfate 7.5 mg iron/0.5 mL oral syringes due to a defective delivery system that may cause leakage after repackaging into unit-dose syringes.
Safecor Health, LLC has issued a voluntary nationwide recall of ferrous sulfate 7.5 mg iron/0.5 mL oral syringes due to a defective delivery system that may cause leakage after repackaging into unit-dose syringes.
Safecor Health, LLC has issued a...
03/12/2025
Pharmacy Learning Network
News
03/12/2025
Safecor Health, LLC has issued a voluntary nationwide recall of simethicone 20 mg per 0.3 mL oral syringes due to a defective delivery system that may cause leakage after the solution is repackaged into unit-dose syringes.
Safecor Health, LLC has issued a voluntary nationwide recall of simethicone 20 mg per 0.3 mL oral syringes due to a defective delivery system that may cause leakage after the solution is repackaged into unit-dose syringes.
Safecor Health, LLC has issued a...
03/12/2025
Pharmacy Learning Network
News
03/12/2025
Zydus Pharmaceuticals (USA) Inc. has issued a nationwide voluntary recall of nelarabine injection, 250 mg/50 mL (5 mg/mL), citing failed impurities and degradation specifications as the reason for withdrawal.
Zydus Pharmaceuticals (USA) Inc. has issued a nationwide voluntary recall of nelarabine injection, 250 mg/50 mL (5 mg/mL), citing failed impurities and degradation specifications as the reason for withdrawal.
Zydus Pharmaceuticals (USA) Inc....
03/12/2025
Pharmacy Learning Network
News
03/10/2025
Adults aged 50 and older with chronic medical conditions, especially those aged 60 and older, have higher rates of hospitalization for respiratory syncytial virus (RSV) infection, suggesting they may benefit most from RSV vaccination.
Adults aged 50 and older with chronic medical conditions, especially those aged 60 and older, have higher rates of hospitalization for respiratory syncytial virus (RSV) infection, suggesting they may benefit most from RSV vaccination.
Adults aged 50 and older with...
03/10/2025
Pharmacy Learning Network
News
03/06/2025
The FDA has issued a Class II recall for Ergocalciferol (Vitamin D) Oral Syringes due to leakage defects, potentially leading to inaccurate dosing and reduced supplement effectiveness nationwide.
The FDA has issued a Class II recall for Ergocalciferol (Vitamin D) Oral Syringes due to leakage defects, potentially leading to inaccurate dosing and reduced supplement effectiveness nationwide.
The FDA has issued a Class II...
03/06/2025
Pharmacy Learning Network
News
03/06/2025
FDA issues a Class II recall for Lorazepam Oral Syringes due to leakage defects, potentially leading to inaccurate dosing and reduced drug effectiveness nationwide.
FDA issues a Class II recall for Lorazepam Oral Syringes due to leakage defects, potentially leading to inaccurate dosing and reduced drug effectiveness nationwide.
FDA issues a Class II recall for...
03/06/2025
Pharmacy Learning Network